ADVERTISEMENT
(Dallas—March 10, 2022—3:31 p.m.) — Cigarette smoke induces severe alterations in the gut microbiome and metabolome and can drive cancer tumor progression, but this may
(Dallas—March 10, 2022, 3:21 p.m.) — Recurrence-free survival (RFS) has been used as a surrogate endpoint for overall survival (OS) in trials involving resectable colorectal
(Dallas—March 12, 2022; 8:30 a.m.) — Despite the well accepted role of liver-directed therapies (LDT) for colorectal cancer liver metastases (CRLM), only a small proportion of
(Dallas—March 12, 8:40 a.m.) — Receipt of guideline-concordant therapy does not appear to differ drastically between urban and rural patients, but rural patients have decreased
(Dallas – March 10, 2022, 4:51 p.m.) — A study presented at the Society of Surgical Oncology 2022 International Conference on Surgical Care has shown
(Dallas—March 11, 2022, 10:01 a.m.) –Triple-negative breast cancer (TNBC) accounts for about 10-15% of all breast cancers and these cancers tend to be more common in
The Society of Surgical Oncology (SSO) has named Anna Polyak, RN, JD, as the new Chief Executive Officer effective April 4, 2022. “After an extensive
SSO’s podcast, SurgOnc Today®, features interviews with surgical oncology leaders and innovators in the field, including SSO Disease Site Work Group (DSWG) Chairs and members.
Each year SSO acknowledges the outstanding work of surgical oncologists with a variety of awards. The following list presents this year’s recipients. The Charles M.
Society of Surgical Oncology
9525 West Bryn Mawr Avenue, Suite 870
Rosemont, IL 60018 / Phone: 847-427-1400
© Society of Surgical Oncology. 2010-2023.
